Projects

AstraZeneca Broad Market Manufacturing Site Project

AstraZeneca, one of the world’s leading Pharma companies, is establishing a new pharmaceutical manufacturing facility in Jiangsu Province, China. Known as China Broad Market Manufacturing Site, in the China Medical City, Taizhou, the 51,000m2 project comprises Sterile dry powder filling for injectable Cephalosporin products, and Oral Solid Dosage products. Phase 1 of the $230M project was recently completed and Phases 2 and 3 are progressing well.